US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist

3.770
-0.110-2.84%

Close Dec 3 16:00 ET

3.620
-0.150-3.98%

Post 18:50 ET

203.35MMarket Cap-13000P/E (TTM)

Fulcrum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

8,990.91%80M

-55.77%2.81M

27.15%871K

-35.84%759K

-53.24%880K

-88.62%295K

-66.90%6.34M

-86.46%685K

Operating revenue

--0

8,990.91%80M

--0

-55.77%2.81M

27.15%871K

-35.84%759K

-53.24%880K

-88.62%295K

-66.90%6.34M

-86.46%685K

Cost of revenue

Gross profit

Operating expense

-18.21%23.06M

-2.36%27.51M

5.66%29.83M

-4.23%113.47M

0.58%28.86M

12.47%28.2M

-22.00%28.17M

-1.24%28.24M

18.22%118.48M

0.28%28.7M

Selling and administrative expenses

-15.43%8.42M

-0.74%10.25M

-12.66%10.06M

-0.06%41.67M

-2.63%9.86M

2.62%9.96M

-6.98%10.32M

7.07%11.52M

36.63%41.69M

4.38%10.13M

-General and administrative expense

-15.43%8.42M

-0.74%10.25M

-12.66%10.06M

-0.06%41.67M

-2.63%9.86M

2.62%9.96M

-6.98%10.32M

7.07%11.52M

36.63%41.69M

4.38%10.13M

Research and development costs

-19.73%14.64M

-3.29%17.26M

18.29%19.77M

-6.49%71.8M

2.33%19M

18.69%18.24M

-28.66%17.85M

-6.26%16.72M

10.16%76.78M

-1.83%18.57M

Operating profit

15.95%-23.06M

292.33%52.49M

-6.78%-29.83M

1.31%-110.66M

0.07%-27.99M

-14.86%-27.44M

20.28%-27.29M

-7.47%-27.94M

-38.34%-112.13M

-18.90%-28.01M

Net non-operating interest income expense

Other net income (expense)

-60.06%1.37M

-16.87%2.92M

-6.23%2.96M

489.00%13.33M

72.49%3.24M

2,151.97%3.42M

2,026.67%3.51M

4,415.71%3.16M

993.24%2.26M

2,401.33%1.88M

Special income (charges)

---2.06M

----

--0

----

---427K

--38K

-Less：Restructuring and merger&acquisition

--2.06M

----

--0

----

--427K

---38K

Other non- operating income (expenses)

0.20%3.43M

-16.87%2.92M

-6.23%2.96M

395.50%13.33M

76.06%3.24M

454.78%3.42M

2,026.67%3.51M

4,415.71%3.16M

1,199.52%2.69M

2,350.67%1.84M

Income before tax

9.66%-21.7M

332.98%55.41M

-8.44%-26.87M

11.41%-97.34M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-35.90%-109.87M

-11.29%-26.14M

Income tax

Net income

9.66%-21.7M

332.98%55.41M

-8.44%-26.87M

11.41%-97.34M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-35.90%-109.87M

-11.29%-26.14M

Net income continuous Operations

9.66%-21.7M

332.98%55.41M

-8.44%-26.87M

11.41%-97.34M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-35.90%-109.87M

-11.29%-26.14M

Minority interest income

Net income attributable to the parent company

9.66%-21.7M

332.98%55.41M

-8.44%-26.87M

11.41%-97.34M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-35.90%-109.87M

-11.29%-26.14M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

9.66%-21.7M

332.98%55.41M

-8.44%-26.87M

11.41%-97.34M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-35.90%-109.87M

-11.29%-26.14M

Basic earnings per share

10.26%-0.35

334.21%0.89

-4.88%-0.43

34.84%-1.59

20.00%-0.4

23.53%-0.39

54.22%-0.38

35.94%-0.41

-6.55%-2.44

13.79%-0.5

Diluted earnings per share

10.26%-0.35

328.95%0.87

-4.88%-0.43

34.84%-1.59

20.00%-0.4

23.53%-0.39

54.22%-0.38

35.94%-0.41

-6.55%-2.44

13.79%-0.5

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	8,990.91%80M	0	-55.77%2.81M	27.15%871K	-35.84%759K	-53.24%880K	-88.62%295K	-66.90%6.34M	-86.46%685K
Operating revenue	--0	8,990.91%80M	--0	-55.77%2.81M	27.15%871K	-35.84%759K	-53.24%880K	-88.62%295K	-66.90%6.34M	-86.46%685K
Cost of revenue
Gross profit
Operating expense	-18.21%23.06M	-2.36%27.51M	5.66%29.83M	-4.23%113.47M	0.58%28.86M	12.47%28.2M	-22.00%28.17M	-1.24%28.24M	18.22%118.48M	0.28%28.7M
Selling and administrative expenses	-15.43%8.42M	-0.74%10.25M	-12.66%10.06M	-0.06%41.67M	-2.63%9.86M	2.62%9.96M	-6.98%10.32M	7.07%11.52M	36.63%41.69M	4.38%10.13M
-General and administrative expense	-15.43%8.42M	-0.74%10.25M	-12.66%10.06M	-0.06%41.67M	-2.63%9.86M	2.62%9.96M	-6.98%10.32M	7.07%11.52M	36.63%41.69M	4.38%10.13M
Research and development costs	-19.73%14.64M	-3.29%17.26M	18.29%19.77M	-6.49%71.8M	2.33%19M	18.69%18.24M	-28.66%17.85M	-6.26%16.72M	10.16%76.78M	-1.83%18.57M
Operating profit	15.95%-23.06M	292.33%52.49M	-6.78%-29.83M	1.31%-110.66M	0.07%-27.99M	-14.86%-27.44M	20.28%-27.29M	-7.47%-27.94M	-38.34%-112.13M	-18.90%-28.01M
Net non-operating interest income expense
Other net income (expense)	-60.06%1.37M	-16.87%2.92M	-6.23%2.96M	489.00%13.33M	72.49%3.24M	2,151.97%3.42M	2,026.67%3.51M	4,415.71%3.16M	993.24%2.26M	2,401.33%1.88M
Special income (charges)	---2.06M	----	----	--0	--0	--0	----	----	---427K	--38K
-Less：Restructuring and merger&acquisition	--2.06M	----	----	--0	--0	--0	----	----	--427K	---38K
Other non- operating income (expenses)	0.20%3.43M	-16.87%2.92M	-6.23%2.96M	395.50%13.33M	76.06%3.24M	454.78%3.42M	2,026.67%3.51M	4,415.71%3.16M	1,199.52%2.69M	2,350.67%1.84M
Income before tax	9.66%-21.7M	332.98%55.41M	-8.44%-26.87M	11.41%-97.34M	5.28%-24.76M	-1.18%-24.02M	30.19%-23.78M	4.43%-24.78M	-35.90%-109.87M	-11.29%-26.14M
Income tax
Net income	9.66%-21.7M	332.98%55.41M	-8.44%-26.87M	11.41%-97.34M	5.28%-24.76M	-1.18%-24.02M	30.19%-23.78M	4.43%-24.78M	-35.90%-109.87M	-11.29%-26.14M
Net income continuous Operations	9.66%-21.7M	332.98%55.41M	-8.44%-26.87M	11.41%-97.34M	5.28%-24.76M	-1.18%-24.02M	30.19%-23.78M	4.43%-24.78M	-35.90%-109.87M	-11.29%-26.14M
Minority interest income
Net income attributable to the parent company	9.66%-21.7M	332.98%55.41M	-8.44%-26.87M	11.41%-97.34M	5.28%-24.76M	-1.18%-24.02M	30.19%-23.78M	4.43%-24.78M	-35.90%-109.87M	-11.29%-26.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	9.66%-21.7M	332.98%55.41M	-8.44%-26.87M	11.41%-97.34M	5.28%-24.76M	-1.18%-24.02M	30.19%-23.78M	4.43%-24.78M	-35.90%-109.87M	-11.29%-26.14M
Basic earnings per share	10.26%-0.35	334.21%0.89	-4.88%-0.43	34.84%-1.59	20.00%-0.4	23.53%-0.39	54.22%-0.38	35.94%-0.41	-6.55%-2.44	13.79%-0.5
Diluted earnings per share	10.26%-0.35	328.95%0.87	-4.88%-0.43	34.84%-1.59	20.00%-0.4	23.53%-0.39	54.22%-0.38	35.94%-0.41	-6.55%-2.44	13.79%-0.5
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data